Small caps

The Emirati royal family has taken a stake in the Crypto Price Index (CPI) project, a cryptocurrency analog of the Dow Jones Industrial Average that operates on the blockchain. The development comes as the royal family believes that volatile and uncertain digital asset markets need...

By Peter Page. A common complaint in the legal cannabis industry is that onerous regulation is bad for business, but Tim Conder, the co-founder of Blackbird and new COO of TILT Holdings Inc (OTC: TLLTF), sees it very differently. The tougher the regulations are, he reasons, the bigger the reward...

The consumer staples sector, the sixth-largest sector weight in the S&P 500, has been rightfully derided as one of this year's worst-performing groups. The Consumer Staples Select Sector SPDR (NYSE: XLP), the largest exchange traded fund tracking the sector, and other traditional cap-...

Cloud computing name salesforce.com, inc. (NYSE: CRM) is likely to report strong fourth-quarter results with sustained demand trickling into its fiscal 2019, according to Morgan Stanley.  The company is scheduled to report after the market close Feb. 28. The Analyst Analyst Keith Weiss...

Myomo Inc (NYSE: MYO) has caught the gaze of some brazen admirers. Ossur and current partner Ottobock “have been inquisitive in the past” about buyout possibilities, Myomo CEO Paul Gudonis told Benzinga Tuesday at the LD Micro Conference. He posited additional merger potential in Asian...

The 10-year anniversary edition of the LD Micro Main Event kicked off Monday, Dec. 4 in Los Angeles, California. The event runs through Thursday. A focus on "many of the most influential companies in the micro-cap space" has helped the LD Micro event win the riotous title "Woodstock...

Root9B Holdings Inc (NASDAQ: RTNB) investors have been rattled since Friday morning when the stock halted seven times on circuit breakers. Since then, Nasdaq halted trading twice pending news and, on Wednesday morning, twice on circuit breakers. The nano-cap stock is up 287 percent since Friday....

Throughout his 20-plus-years with Marcum LLP, an independent auditor of public companies, David Bukzin has played witness to the contraction of the IPO market. As the founding head of Marcum’s SEC Services practice, Bukzin supports entrepreneurial companies that opt to migrate into the public...

Meet Orexigen Therapeutics, Inc. (NASDAQ: OREX), a micro-cap biopharmaceutical company delivering one of the strongest stock market performances of 2017 so far. After losing almost 90 percent of its value over 2016, shares have recuperated more than 80 percent this year. Benzinga recently spoke...

Low fees on exchange-traded funds are one of the biggest selling points of this asset class and one of the primary reasons investors are continually ditching higher-fee, under-performing actively managed mutual funds. Lower Fees Attract Assets Even better for investors is that ETF issuers are...

A concern many investors have when mulling small-cap stocks or related exchange-traded funds is the often high valuations that come with the growth opportunity offered by smaller stocks. Finding value with small-caps has proven potent over time. In fact, long-term data suggest small-cap value funds...

U.S. small-cap stocks are among this year's most notable laggards. Something else that has been widely documented is the outperformance offered by ex-U.S. small-caps, a scenario pertaining to both developed and emerging markets smaller stocks. Speaking of outperformance courtesy of emerging...

VBI Vaccines Inc. - Ordinary Shares (NASDAQ: VBIV) has emerged as one of the best performing small-cap biotech plays of the year, with shares of the Cambridge, Massachusetts-based company quietly jumping over 75 percent year-to-date. With several new vaccines in the pipeline, analysts believe there...

There are massive sums of money sitting in various small-cap exchange traded funds, but in some cases, investors may not be getting the small-cap purity they signed up. Part of the reason for this could be that there isn't a uniform definition of “small cap,” though widely accepted...

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) shares have historically outperformed during product launches, and Credit Suisse’s Kennen MacKay expects the Brineura launch in Q2:17 and upcoming launches of Vosoritide and PEG-PAL to drive earnings as well as investor interest. MacKay initiated...